- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00254228
Safety and Efficacy of the BrainPort™ Balance Device to Improve Balance in Bilateral Vestibular Hypofunction
A Clinical Study to Evaluate the Safety and Efficacy of the BrainPort™ Balance Device When Used to Improve Postural Control in Subjects With Bilateral Vestibular Disorders
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
People with Bilateral Vestibular Dysfunction (BVD) often experience disabling symptoms, greatly affecting their quality of life and ability to work. Current vestibular treatment does not always allow these patients to fully recover. Many patients either do not improve or reach a plateau with conventional vestibular rehabilitation, and still have difficulty with daily function. The BrainPort™ balance device is intended to provide information about head position to the brain through electrotactile stimulation of the tongue to improve balance in subjects with vestibular disorders.
This study is a prospective, multi-center, randomized double-blinded study comparing the postural stability of BVD subjects using the BrainPort™ balance device to postural stability of control subjects using a sham device and respective baseline measures for each group. The primary objective of this study is to determine whether electrotactile stimulation of the tongue, using the BrainPort™ balance device, can improve postural stability, as measured by improvement in performance of the composite Computerized Dynamic Posturography using the NeuroCom® Sensory Organization Test in subjects with chronic bilateral vestibular dysfunction (BVD). The secondary objectives are to evaluate improvement in quality of life, as measured by the Activities Specific Balance Confidence (ABC) Scale, Dizziness Handicap Inventory (DHI), and the Dynamic Gait Index (DGI), and to demonstrate a decreased number of falls on the NeuroCom® Sensory Organization Test. In addition, we will monitor the number of falls that occur during subjects' normal activities of daily living. The long-term objective is to evaluate the safety and efficacy when the device is used over a one-year period.
Study Type
Enrollment
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Kent, United Kingdom, ME7 5NY
- Medway Balance Centre
-
-
-
-
Florida
-
Jacksonville, Florida, United States, 32224
- Mayo Clinic
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Mayo Clinic
-
-
Missouri
-
St. Louis, Missouri, United States, 63110
- Washington University
-
-
Wisconsin
-
Madison, Wisconsin, United States, 53792
- University of Wisconsin, Madison
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Documented history of acquired bilateral vestibular dysfunction for a duration of at least one year which has been unsuccessfully treated or reached a plateau with conventional vestibular rehabilitation.
- No greater than 2 successful attempts out of 6 on the NeuroCom Equitest Sensory Organization Tests 5 and 6.
- Failure on the Rotary Chair Vestibulo-ocular Reflex (VOR) Test as evidenced by a gain of less than or equal to -2 standard deviations at frequencies of .025, and .05 Hz.
- Normal corrected vision (20/40 or better).
- Able to read and understand the informed consent form, and willing to sign the informed consent form.
- Willing to complete all follow-up evaluations required by the study protocol.
- Able to stand for a period of 20 minutes in a stationary position with weight evenly distributed without moderate pain, muscle cramping or numbness in the lower extremities.
Exclusion Criteria:
- Neurological disorders other than bilateral vestibular disorder, as determined by medical history and neurological screening procedure.
- Current oral health problems as determined by health questionnaire and an examination of the oral cavity.
- Cigarette smokers and those who use chewing tobacco.
- Currently taking either benzodiazepine or barbiturate medication.
- Any medical condition as determined by the health questionnaire that would interfere with performance on the postural stability evaluation tests.
- Known neuropathies of tongue or skin tactile system.
- Peripheral neuropathies of the lower extremities.
- Prior exposure to BrainPort™ balance device (does not apply to control group subjects who cross over).
- Subjects who are unwilling or unable to adhere to all study requirements, including completion of the training period, evaluation tests, and return to clinic for a follow-up visit.
- Subjects who have undergone middle ear or other surgery with sacrifice or damage to the chorda tympani, lingual, or hypoglossal nerve.
- Subjects who have an implanted device such as a pacemaker or defibrillator.
- If the subject is female, she is pregnant.
- If the subject is unwilling to discontinue medications for dizziness or imbalance 48 hours prior to beginning the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
Computerized Dynamic Posturography using the NeuroCom Sensory Organization Test (SOT) composite score, taken at baseline, 1 week, 8 weeks and 12 months.
|
Secondary Outcome Measures
Outcome Measure |
---|
Activities-specific Balance Confidence Scale (ABC)
|
Dizziness Handicap Inventory (DHI)
|
Dynamic Gait Index (DGI)
|
Number of falls on the NeuroCom SOT
|
Functional Objective Tests i.e. standing with eyes closed, on one leg, etc.
|
All tests taken at baseline, 1 week, 8 weeks and 12 months.
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Yuri P Danilov, PhD, Wicab
Publications and helpful links
General Publications
- Bach-y-Rita P, W Kercel S. Sensory substitution and the human-machine interface. Trends Cogn Sci. 2003 Dec;7(12):541-6. doi: 10.1016/j.tics.2003.10.013.
- Tyler M, Danilov Y, Bach-Y-Rita P. Closing an open-loop control system: vestibular substitution through the tongue. J Integr Neurosci. 2003 Dec;2(2):159-64. doi: 10.1142/s0219635203000263.
- Bach-y-rita P, Danilov YP, Tyler ME, Grimm RF. Late Human Brain Plasticity: Vestibular Substitution with a Tongue BrainPort Human-Machine Interface. Journal Intellectica, 2005 (in press).
- Bach-Y-Rita P. Emerging concepts of brain function. J Integr Neurosci. 2005 Jun;4(2):183-205. doi: 10.1142/s0219635205000768.
Helpful Links
Study record dates
Study Major Dates
Study Start
Study Completion
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- WCB1-001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vestibular Disease
-
Istanbul Medipol University HospitalCompletedVestibular Disease | Vestibular RehabilitationTurkey
-
Hospital de Rehabilitacion Manuel RoccaActive, not recruitingVestibular Disease | Peripheral Vestibular DisorderArgentina
-
Istanbul Gelisim UniversityCompletedUnilateral Vestibular Dysfunction DiseaseTurkey
-
Combined Military Hospital QuettaRecruitingVestibular Disorder PreservationPakistan
-
University of the Basque Country (UPV/EHU)BioarabaRecruitingVestibular Disease | Vestibular Disorder | Vestibular VertigoSpain
-
University of ManitobaCompletedVestibular Neuronitis | Peripheral Vestibular Disorders | Vestibular Syndromes &/or Disorders (Labyrinthine)Canada
-
University of PittsburghUniversity of Michigan; National Institute on Deafness and Other Communication...Completed
-
Groupe Hospitalier Paris Saint JosephCompletedEmergencies | Acute Vestibular SyndromeFrance
-
University of RochesterNational Institute on Deafness and Other Communication Disorders (NIDCD)Recruiting
-
Ege UniversityCompletedVestibular Disorder | Peripheral Vestibular DisorderTurkey
Clinical Trials on Electrotactile sensory substitution
-
University of North Carolina, Chapel HillNestle Waters North America, IncCompleted
-
Universitaire Ziekenhuizen KU LeuvenCompleted
-
Sohag UniversityNot yet recruitingUrethral Stricture, MaleEgypt
-
Brain and Cognition Discovery FoundationTakeda; Cognition Kit; Ctrl Group, LtdCompleted
-
University Medicine GreifswaldWithdrawnPulmonary Hypertension | Pulmonary ResistanceGermany
-
Peking UniversityHealth Science Center of Xi'an Jiaotong University; Changzhi Medical College; Hohhot Center for Disease Control and Prevention and other collaboratorsCompleted
-
The S.N. Fyodorov Eye Microsurgery State InstitutionRecruitingLimbal Stem-cell DeficiencyRussian Federation
-
Johns Hopkins Bloomberg School of Public HealthMushroom CouncilCompleted
-
Pauls Stradins Clinical University HospitalCompletedVitamin D3 DeficiencyLatvia
-
Al-Azhar UniversityRecruitingAnterior Urethral Stricture, MaleEgypt